Antigen News and Research

RSS

Circulating tumor cells predict how prostate cancer patients do with chemotherapy

The number of tumor cells circulating in the bloodstream of patients with metastatic, hormone-resistant, prostate cancer can predict how they will do with chemotherapy, according to results of an international trial.

5 Jun 2007

Bone-targeting radioisotope radium-223 for prostate cancer treatment

The bone-targeting radioisotope radium-223 has delivered promising results in a randomised trial to test its efficacy in treatment of hormone-refractory prostate cancer (HRPC).

5 Jun 2007

Findings from study of immunotherapy vaccine in prostate cancer patients

Data from an ongoing study designed to explore the biologic and clinical activity of cancer immunotherapy sipuleucel-T, or Provenge, in patients with early stage recurrent prostate cancer who have a rising serum prostate specific antigen (PSA) level, but who have not yet developed metastatic disease will be presented by Oregon Health & Science University Cancer Institute researchers.

5 Jun 2007

Exposure to flu vaccine kick-starts fetal immune system in pregnant mothers

Some researchers have hypothesized that the fetus can be exposed to and mount an immune response against allergens to which the mother has been exposed, and this may have an effect on the development of allergic sensitivity (e.g. eczema and asthma) later in an infant's life.

3 Jun 2007

BioGenex settles patent case with Ventana

BioGenex Laboratories announced a settlement of patent litigation with Ventana Medical Systems (VMSI), ending the dispute between the two companies.

3 Jun 2007

New tests for leishmaniasis and leprosy

The Seattle-based Infectious Disease Research Institute (IDRI) and Chembio Diagnostics, Inc. have entered into two research and development agreements for the development of rapid diagnostic tests for Leishmaniasis and Leprosy, two "neglected diseases" targeted by IDRI.

1 Jun 2007

Significant breakthrough in the search for an effective malaria vaccine

One person dies of it every 30 seconds, it rivals HIV and tuberculosis as the world's most deadly infection and the vast majority of its victims are under five years old.

28 May 2007

Researchers successfully treated type 1 diabetic mice with a vaccination

The vaccine they designed in this model included structures that the immune system mistakenly attacks in type 1 diabetes.

28 May 2007

High pretreatment PSA velocity predicts worse outcome

The most significant single predictor of aggressive prostate cancer is an elevated rate of increase in prostate specific antigen (PSA) levels, according to a new study.

28 May 2007

Flu vaccine patch a disappointment

A flu vaccine administered via a skin patch has produced disappointing results at a phase 1 clinical trial.

28 May 2007

Significant breakthrough in the search for an effective malaria vaccine

One person dies of it every 30 seconds, it rivals HIV and tuberculosis as the world's most deadly infection and the vast majority of its victims are under five years old.

24 May 2007

Diagnostic tests for Malaria are often underused in Zambia

Despite improvements in the ability to diagnose malaria, these diagnostic tests are often underused in Zambia, and patients with negative test results are often prescribed anti-malaria medications, according to a study in the May 23/30 issue of JAMA , a theme issue on malaria.

24 May 2007

Laparoscopic radical prostatectomy with robot technology can improve survival rate for prostate cancer patients

Performing less invasive laparoscopic surgery using robotic technology may improve survival rates for prostate cancer patients, according to a study by urologic oncologists at Thomas Jefferson University Hospital's multidisciplinary Genitourinary (GU) cancer center.

22 May 2007

Scientists develop method to track immune system enzyme in live animals

Scientists supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) at the National Institutes of Health have created two mouse strains that will permit researchers to trace, in a live animal, the activity of an enzyme believed to play a crucial role both in the normal immune response as well as autoimmunity and B cell tumor development.

18 May 2007

Antibody-based therapies effective at controlling malaria

Passive immunization through the development of fully human antibodies specific to Plasmodium falciparum may be effective at controlling the disease, report researchers led by Dr. Richard S.

18 May 2007

Yin Yang 1 regulates early B cell development

A new paper in the May 15th issue of Genes & Development reveals how a protein called Yin Yang 1 regulates early B cell development.

17 May 2007

New vaccine breakthrough for respiratory syncytial virus

Respiratory syncytial virus (RSV) infection is a widespread infant illness that has been linked to asthma and can be deadly but may be curable by the development of this new vaccine technology by the Sir Albert Sakzewski Virus Research Centre and The University of Queensland's Faculty of Biological and Chemical Sciences.

9 May 2007

Study on cerebral malaria in children living in an endemic region

Scientists at CNRS and the Pasteur Institute, collaborating with physicians in Gabon, have just undertaken a study on cerebral malaria in children living in an endemic region.

4 May 2007

LigoCyte Pharmaceuticals presents data showing that immunization with their influenza H1N1-VLP formulation resulted in 100% protection from H1N1 and H3N2

LigoCyte Pharmaceuticals has presented preclinical data showing that immunization with their influenza virus-like particles (VLPs) induced heterosubtypic protection in a virus challenge study.

4 May 2007

Cancer Research Technology licenses therapeutic antibodies to Peptech

Cancer Research Technology Limited (CRT), the oncology-focused development and commercialisation company, today announces it has licensed rights to a panel of cancer therapeutic antibodies to Peptech Limited.

2 May 2007